Bivirkningsfrekvens identificeret i placebo- kontrollerede kliniske undersøgelser
No adverse reactions considered as drug-related were reported in patients treated with sitagliptin occurring in excess (> 0.2% and difference > 1 patient) of that in patients treated with control.